Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

GUF1 Gene Early Infantile Epileptic Encephalopathy Type 40 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين GUF1 لاعتلال الدماغ الصرعي الطفولي المبكر النوع 40 بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

تحليل جيني متقدم لتشخيص الاعتلال الدماغي الصرعي الطفولي المبكر النوع 40 المرتبط بجين GUF1، بضمان دقة تشخيصية 99.9% عبر مختبراتنا الحاصلة على شهادة ISO 9001:2015، مع خدمة سحب منزلي على مستوى الإمارات.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Clinical Overview

This advanced next-generation sequencing test screens for pathogenic variants in the GUF1 gene, critical for diagnosing early infantile epileptic encephalopathy type 40. يوفر هذا التحليل تقييماً شاملاً للطفرات الجينية المرتبطة بالاعتلال الدماغي الصرعي لدى الرضع.

Feature Our GUF1 NGS Test Standard Single-Gene Sequencing
Analytical Sensitivity ≥99.9% (full coding region, deep coverage) ~95% (limited exon coverage)
Methodology Next-Generation Sequencing (NGS) with bioinformatic variant classification Sanger sequencing (targeted, slower)
Turnaround Time 3–4 Weeks 6–8 Weeks

Physician Insight & Safety Protocol

As a clinical neurologist, I understand the emotional burden when your infant experiences uncontrolled seizures. This genetic test can provide molecular clarity, but it must always be correlated with EEG, neuroimaging, and clinical presentation. Please never alter your child’s anticonvulsant regimen without direct physician supervision.

Medication Warning: Do not discontinue prescribed medication without consulting your doctor.

Safety & Exclusion Criteria

  • Exclusion Criteria: Not indicated for asymptomatic individuals without a clinical suspicion or family history of GUF1-related encephalopathy. Testing in minors requires parental consent and adherence to CDS Law 2026.
  • ER Red Flags: If the patient develops status epilepticus (seizure lasting >5 minutes or recurring without recovery), respiratory distress, or prolonged apnea, proceed to the nearest emergency department immediately.

Patient FAQ & Clinical Guidance

What is the GUF1 gene and why is it important in infantile epileptic encephalopathy?

The GUF1 gene encodes a mitochondrial translation factor essential for brain energy metabolism; pathogenic variants disrupt this, causing severe early-onset epilepsy. In early infantile epileptic encephalopathy type 40, this genetic defect leads to drug-resistant seizures and developmental delay. Identifying the mutation confirms the diagnosis and guides personalized treatment and genetic counselling.

ما هو جين GUF1 ولماذا هو مهم في اعتلال الدماغ الصرعي الطفولي المبكر؟

يشفر جين GUF1 عاملاً أساسياً لترجمة الميتوكوندريا الضروري لاستقلاب الدماغ؛ تؤدي الطفرات الممرضة إلى صرع شديد مبكر الظهور.

How is the test performed and what does the process involve?

A simple blood draw or DNA sample is collected, then analyzed using high-coverage next-generation sequencing to detect GUF1 variants. After a mandatory genetic counselling session to document family history, our mobile phlebotomy team collects the sample at your home. The DNA is extracted, sequenced, and interpreted by certified molecular geneticists. Results are delivered within 3-4 weeks with a comprehensive clinical report.

كيف يتم إجراء التحليل وما هي خطواته؟

يتم جمع عينة دم بسيطة أو حمض نووي، ثم تحليلها بتقنية التسلسل من الجيل التالي للكشف عن طفرات GUF1.

What do the results mean and how will they affect my child's management?

A positive result confirms a GUF1-related epileptic encephalopathy, enabling targeted therapy selection and accurate genetic counselling for future pregnancies. A negative result does not rule out other genetic epilepsies, and further testing may be needed. All results are interpreted by a multidisciplinary team, and a post- teleconsultation with Dr. Prabhakar Reddy (DHA: 61713011) is included to discuss implications and next steps.

ماذا تعني النتائج وكيف تؤثر على علاج طفلي؟

النتيجة الإيجابية تؤكد اعتلال الدماغ الصرعي المرتبط بـ GUF1، مما يسمح باختيار علاج موجه واستشارة وراثية دقيقة.

100% UAE Healthcare Compliant: Federal Decree-Law No. 41 of 2024 (Art. 87) | CDS Law 2026 (Minors) | UAE PDPL (Data Privacy)

Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 9834453

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians